9:27 AM
Leo Group India
| ||
| Drug Sales in Emerging Markets to Match US by 2016 Bloomberg Rising drug spending in 16 emerging pharmaceutical markets will lead the industry's global sales growth by 2016, according to a report released today by the IMS Institute for Healthcare Informatics, a Parsippany, New Jersey-based research arm of drug ... See all stories on this topic » | ||
| Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics MarketWatch (press release) SAN DIEGO, July 12, 2012 /PRNewswire via COMTEX/ -- Conatus Pharmaceuticals Inc. announced today the appointment of Mark F. Morris as Head of Biostatistics effective immediately. In this newly created position, Mr. Morris will oversee the statistical ... See all stories on this topic » | ||
| Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief ... MarketWatch (press release) Kala Pharmaceuticals, Inc. is developing innovative products which are capable of penetrating mucosal barriers for the treatment of major diseases that affect the eyes, lungs, gastrointestinal tract, and female reproductive system. Mucosal barriers ... See all stories on this topic » | ||
| Catalyst Pharmaceutical Partners to Announce Top-Line Data From CPP-109 ... MarketWatch (press release) CORAL GABLES, Fla., Jul 12, 2012 (GlobeNewswire via COMTEX) -- Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) today announced that it expects to report top-line results from its CPP-109 (vigabatrin) Phase II(b) trial around the end of September ... See all stories on this topic » | ||
| Generics seen cutting into drug sales growth through 2016 Reuters IMS sees generics gaining much ground on branded drugs* Sees annual U.S. drug spending growing 1 to 4 pct* Sees emerging market drug spending growing 12 to 15 pctBy Ransdell PiersonJuly 12 (Reuters) See all stories on this topic » | ||
| Cubist Pharmaceuticals Enrolls 1st Patient in Phase 3 Trial for Therapy to ... MarketWatch (press release) LEXINGTON, Mass., Jul 12, 2012 (BUSINESS WIRE) -- Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced the initiation of its pivotal Phase 3 studies evaluating the efficacy and safety of CB-315 in patients with Clostridium difficile-associated ... See all stories on this topic » | ||
| Kala Pharmaceuticals taps ex-Sanofi exec as its CEO Boston Herald Waltham biotechnology company Kala Pharmaceuticals Inc. said today it has appointed Guillaume Pfefer, former general manager of Sanofi Pasteur Mexico, as its first president and chief executive officer and a member of its board of directors. The ... See all stories on this topic » | ||
| Drug Makers' Growth Seen in Emerging Markets New York Times Rising incomes among consumers in emerging markets like China, India and Brazil are poised to drive global growth in pharmaceutical spending over the next five years, according to a report released Thursday by the IMS Institute for Healthcare Informatics. See all stories on this topic » | ||
| Raptor Pharmaceutical Corp. Announces Third Quarter Fiscal 2012 Financial ... MarketWatch (press release) NOVATO, Calif., Jul 11, 2012 (GlobeNewswire via COMTEX) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (NASDAQ:RPTP) , today provided an update on the Company's business and announced financial results for the third quarter ended ... See all stories on this topic » | ||
| Watson and Actavis Receive FTC Second Request MarketWatch (press release) PARSIPPANY, N.J., July 12, 2012 /PRNewswire via COMTEX/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) , a leading specialty pharmaceutical company, today announced that it has received a request for additional information from the Federal Trade ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment